Less Ads, More Data, More Tools Register for FREE

Pin to quick picksATK.L Regulatory News (ATK)

  • There is currently no data for ATK

Form 8.3 - WS Atkins Plc

28 Apr 2017 11:53

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose WS Atkins Plc
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 27 April 2017
(f) In addition to the company in 1(c) above, is the discloser making NO
disclosures in respect of any other party to the offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 0.5p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 957,158 0.96% 384,332 0.38%
(2) Cash-settled derivatives:
151,004 0.15% 826,041 0.83%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
(4)
TOTAL: 1,108,162 1.11% 1,210,373 1.21%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
0.5p ordinary Purchase 34 21.0234 GBP
0.5p ordinary Purchase 52 21.0219 GBP
0.5p ordinary Purchase 91 21.0613 GBP
0.5p ordinary Purchase 144 21.0700 GBP
0.5p ordinary Purchase 161 21.0400 GBP
0.5p ordinary Purchase 171 21.0394 GBP
0.5p ordinary Purchase 225 21.0200 GBP
0.5p ordinary Purchase 318 21.0481 GBP
0.5p ordinary Purchase 333 21.0500 GBP
0.5p ordinary Purchase 555 21.0364 GBP
0.5p ordinary Purchase 593 21.0300 GBP
0.5p ordinary Purchase 622 21.0283 GBP
0.5p ordinary Purchase 2,418 21.0420 GBP
0.5p ordinary Purchase 2,667 21.0281 GBP
0.5p ordinary Purchase 3,682 21.0600 GBP
0.5p ordinary Purchase 4,396 21.0560 GBP
0.5p ordinary Purchase 5,015 21.0338 GBP
0.5p ordinary Purchase 48,004 21.0334 GBP
0.5p ordinary Sale 85 21.0476 GBP
0.5p ordinary Sale 139 21.0465 GBP
0.5p ordinary Sale 161 21.0400 GBP
0.5p ordinary Sale 333 21.0500 GBP
0.5p ordinary Sale 588 21.0200 GBP
0.5p ordinary Sale 609 21.0300 GBP
0.5p ordinary Sale 787 21.0332 GBP
0.5p ordinary Sale 1,188 21.0700 GBP
0.5p ordinary Sale 1,410 21.0263 GBP
0.5p ordinary Sale 2,295 21.0394 GBP
0.5p ordinary Sale 3,275 21.0609 GBP
0.5p ordinary Sale 3,672 21.0600 GBP

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
0.5p ordinary CFD Long 85 21.0476 GBP
0.5p ordinary SWAP Long 89 21.0369 GBP
0.5p ordinary SWAP Long 645 21.0559 GBP
0.5p ordinary SWAP Long 1,013 21.0096 GBP
0.5p ordinary SWAP Long 1,681 21.0697 GBP
0.5p ordinary CFD Short 34 21.0235 GBP
0.5p ordinary CFD Short 91 21.0613 GBP
0.5p ordinary CFD Short 430 21.0328 GBP
0.5p ordinary SWAP Short 550 21.0298 GBP
0.5p ordinary SWAP Short 1,250 21.0373 GBP
0.5p ordinary CFD Short 2,418 21.0420 GBP
0.5p ordinary SWAP Short 4,225 21.0267 GBP
0.5p ordinary CFD Short 7,362 21.0383 GBP
0.5p ordinary CFD Short 41,629 21.0346 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 28 Apr 2017
Contact name: Rajesh Muthanna
Telephone number: 020 3555 4634

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170428005314/en/

Copyright Business Wire 2017

Date   Source Headline
20th Jul 20153:29 pmRNSDirector/PDMR Shareholding
15th Jul 20154:49 pmRNSHolding(s) in Company
26th Jun 20153:38 pmRNSDirector/PDMR Shareholding
26th Jun 20153:34 pmRNSDirector/PDMR Shareholding
25th Jun 20154:51 pmRNSAnnual Financial Report
22nd Jun 20155:01 pmRNSHolding(s) in Company
17th Jun 201512:04 pmRNSDirector/PDMR Shareholding
15th Jun 20155:53 pmRNSHolding(s) in Company
11th Jun 20157:00 amRNSFinal Results
10th Jun 20157:00 amRNSDirectorate Change
9th Jun 20152:00 pmRNSDirectorate Change
19th May 20152:13 pmRNSDirector/PDMR Shareholding
17th Apr 20151:39 pmRNSDirector/PDMR Shareholding
8th Apr 20157:00 amRNSTrading Statement
19th Mar 20157:00 amRNSAnalyst Presentation
18th Mar 20156:17 pmRNSDirector/PDMR Shareholding
18th Mar 20154:25 pmRNSDirector/PDMR Shareholding
18th Feb 20154:33 pmRNSDirector/PDMR Shareholding
18th Feb 20154:19 pmRNSDirector/PDMR Shareholding
11th Feb 20157:00 amRNSThird Quarter Trading Update
4th Feb 20155:27 pmRNSHolding(s) in Company
20th Jan 20154:48 pmRNSDirector/PDMR Shareholding
20th Jan 201512:20 pmRNSDirector Declaration
19th Jan 201510:06 amRNSDirector/PDMR Shareholding
15th Jan 20154:41 pmRNSDirector/PDMR Shareholding
12th Jan 20154:45 pmRNSDirector/PDMR Shareholding
6th Jan 20154:25 pmRNSDirector/PDMR Shareholding
17th Dec 20149:56 amRNSDirector/PDMR Shareholding
12th Dec 20143:50 pmRNSDirector/PDMR Shareholding
12th Dec 20141:49 pmRNSDirector/PDMR Shareholding
1st Dec 20144:26 pmRNSHolding(s) in Company
24th Nov 20144:16 pmRNSDirector/PDMR Shareholding
19th Nov 20144:31 pmRNSDirector/PDMR Shareholding
19th Nov 20144:14 pmRNSDirector/PDMR Shareholding
18th Nov 20144:07 pmRNSDirector/PDMR Shareholding
17th Nov 20145:18 pmRNSDirector/PDMR Shareholding
17th Nov 20145:03 pmRNSHolding(s) in Company
13th Nov 20147:00 amRNSHalf Yearly Report
7th Nov 20142:20 pmRNSHolding(s) in Company
6th Nov 20142:27 pmRNSHolding(s) in Company
16th Oct 20143:35 pmRNSDirector/PDMR Shareholding
2nd Oct 20147:00 amRNSAnalyst Presentation
1st Oct 20147:00 amRNSAcquisition
29th Sep 20144:12 pmRNSDirector/PDMR Shareholding
26th Sep 20145:01 pmRNSHolding(s) in Company
26th Sep 20142:15 pmRNSHolding(s) in Company
25th Sep 20147:00 amRNSTrading Statement
17th Sep 20144:30 pmRNSDirector/PDMR Shareholding
12th Sep 201411:01 amRNSHolding(s) in Company
8th Sep 20147:00 amRNSAtkins acquires US based nuclear business

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.